MIM
IMA

MetLife Investment Management’s ImageneBio Inc IMA Stock Holding History

MetLife Investment Management’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,010
Closed -$79.5K – 2930
2023
Q2 		$79.5K Buy
+1,010
New +$72.4K ﹤0.01% 2807
2022
Q1 		– Sell
-979
Closed -$147K – 2748
2021
Q4 		$147K Buy
+979
New +$159K ﹤0.01% 2249

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MetLife Investment Management's IMA Position: Q3 2023 in Review

MetLife Investment Management sold out of ImageneBio Inc (IMA) in Q3 2023, closing a stake of 1,010 shares — an estimated $79.5K sold.

MetLife Investment Management first reported a position in IMA in Q4 2021 and held it in 2 quarters. The position peaked at $147K in Q4 2021. 58 funds tracked by Wall St. Rank hold IMA as of Q3 2023.

  • MetLife Investment Management reported no remaining ImageneBio Inc position as of Q3 2023 after selling out during the quarter.
  • MetLife Investment Management sold 1,010 ImageneBio Inc shares in Q3 2023, an estimated $79.5K.
  • MetLife Investment Management first reported a position in ImageneBio Inc in Q4 2021 and held it in 2 quarters.
  • MetLife Investment Management's ImageneBio Inc position peaked at $147K in Q4 2021.
  • 58 funds tracked by Wall St. Rank held ImageneBio Inc as of Q3 2023.

Based on MetLife Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.